Enzo Biochem (ENZ) Revenue & Revenue Breakdown
Enzo Biochem Revenue Highlights
Latest Revenue (Y)
$31.06M
Latest Revenue (Q)
$8.02M
Main Segment (Y)
Consolidated Member
Main Geography (Y)
UNITED STATES
Enzo Biochem Revenue by Period
Enzo Biochem Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-07-31 | $31.06M | -70.99% |
| 2022-07-31 | $107.07M | -9.05% |
| 2021-07-31 | $117.73M | 54.87% |
| 2020-07-31 | $76.02M | -6.34% |
| 2019-07-31 | $81.17M | -22.48% |
| 2018-07-31 | $104.71M | -2.87% |
| 2017-07-31 | $107.80M | 4.90% |
| 2016-07-31 | $102.77M | 5.30% |
| 2015-07-31 | $97.60M | 1.72% |
| 2014-07-31 | $95.95M | 2.39% |
| 2013-07-31 | $93.71M | -9.10% |
| 2012-07-31 | $103.08M | 1.03% |
| 2011-07-31 | $102.03M | 5.10% |
| 2010-07-31 | $97.08M | 8.38% |
| 2009-07-31 | $89.57M | 15.14% |
| 2008-07-31 | $77.80M | 47.04% |
| 2007-07-31 | $52.91M | 32.85% |
| 2006-07-31 | $39.83M | -8.24% |
| 2005-07-31 | $43.40M | 4.22% |
| 2004-07-31 | $41.64M | -21.08% |
| 2003-07-31 | $52.77M | -2.31% |
| 2002-07-31 | $54.02M | -7.52% |
| 2001-07-31 | $58.41M | 16.75% |
| 2000-07-31 | $50.03M | 12.93% |
| 1999-07-31 | $44.30M | 9.65% |
| 1998-07-31 | $40.40M | 15.76% |
| 1997-07-31 | $34.90M | 1.16% |
| 1996-07-31 | $34.50M | 8.83% |
| 1995-07-31 | $31.70M | 39.04% |
| 1994-07-31 | $22.80M | 14.00% |
| 1993-07-31 | $20.00M | - |
Enzo Biochem generated $31.06M in revenue during NA 2023, up -70.99% compared to the previous quarter, and up 29.66% compared to the same period a year ago.
Enzo Biochem Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-04-30 | $8.02M | -6.21% |
| 2024-01-31 | $8.55M | 9.57% |
| 2023-10-31 | $7.81M | -139.70% |
| 2023-07-31 | $-19.66M | -222.06% |
| 2023-04-30 | $16.11M | -1.41% |
| 2023-01-31 | $16.34M | -10.60% |
| 2022-10-31 | $18.28M | -9.90% |
| 2022-07-31 | $20.28M | -22.65% |
| 2022-04-30 | $26.22M | -22.98% |
| 2022-01-31 | $34.05M | 28.38% |
| 2021-10-31 | $26.52M | 6.88% |
| 2021-07-31 | $24.81M | -24.34% |
| 2021-04-30 | $32.80M | 4.23% |
| 2021-01-31 | $31.47M | 9.81% |
| 2020-10-31 | $28.66M | 46.75% |
| 2020-07-31 | $19.53M | 15.52% |
| 2020-04-30 | $16.90M | -12.80% |
| 2020-01-31 | $19.38M | -4.07% |
| 2019-10-31 | $20.21M | -3.41% |
| 2019-07-31 | $20.92M | 6.40% |
| 2019-04-30 | $19.66M | 1.73% |
| 2019-01-31 | $19.33M | -9.09% |
| 2018-10-31 | $21.26M | -13.06% |
| 2018-07-31 | $24.45M | -4.58% |
| 2018-04-30 | $25.63M | -4.91% |
| 2018-01-31 | $26.95M | -2.62% |
| 2017-10-31 | $27.68M | -1.76% |
| 2017-07-31 | $28.17M | 4.00% |
| 2017-04-30 | $27.09M | 3.16% |
| 2017-01-31 | $26.26M | -0.09% |
| 2016-10-31 | $26.28M | -1.20% |
| 2016-07-31 | $26.60M | 0.64% |
| 2016-04-30 | $26.43M | 7.63% |
| 2016-01-31 | $24.56M | -2.45% |
| 2015-10-31 | $25.18M | -2.02% |
| 2015-07-31 | $25.70M | 7.13% |
| 2015-04-30 | $23.99M | 3.87% |
| 2015-01-31 | $23.09M | -6.98% |
| 2014-10-31 | $24.82M | -0.33% |
| 2014-07-31 | $24.91M | 3.87% |
| 2014-04-30 | $23.98M | 4.58% |
| 2014-01-31 | $22.93M | -5.00% |
| 2013-10-31 | $24.13M | 3.71% |
| 2013-07-31 | $23.27M | 2.97% |
| 2013-04-30 | $22.60M | 1.75% |
| 2013-01-31 | $22.21M | -13.34% |
| 2012-10-31 | $25.63M | -2.95% |
| 2012-07-31 | $26.41M | 1.78% |
| 2012-04-30 | $25.95M | 3.91% |
| 2012-01-31 | $24.97M | -3.03% |
| 2011-10-31 | $25.75M | -3.96% |
| 2011-07-31 | $26.82M | 3.83% |
| 2011-04-30 | $25.83M | 8.82% |
| 2011-01-31 | $23.73M | -7.48% |
| 2010-10-31 | $25.65M | 2.83% |
| 2010-07-31 | $24.95M | 4.86% |
| 2010-04-30 | $23.79M | 2.60% |
| 2010-01-31 | $23.19M | -7.86% |
| 2009-10-31 | $25.16M | 2.58% |
| 2009-07-31 | $24.53M | 6.37% |
| 2009-04-30 | $23.06M | 10.26% |
| 2009-01-31 | $20.92M | -0.70% |
| 2008-10-31 | $21.06M | -0.53% |
| 2008-07-31 | $21.18M | 11.75% |
| 2008-04-30 | $18.95M | 3.97% |
| 2008-01-31 | $18.23M | - |
Enzo Biochem generated $8.02M in revenue during Q3 2024, up -6.21% compared to the previous quarter, and up 49.10% compared to the same period a year ago.
Enzo Biochem Revenue Breakdown
Enzo Biochem Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Jul 22 | Jul 21 | Jul 20 | Jul 19 | Jul 18 |
|---|---|---|---|---|---|
| Consolidated Member | $107.07M | - | - | - | - |
| ConsolidatedMember | - | $117.73M | - | - | - |
| LifeSciencesProductsMember | - | $30.75M | - | - | - |
| ClinicalLaboratoryServicesMember | - | $86.98M | - | - | - |
| ClinicalServicesMember | - | - | $24.89M | - | - |
| ClinicalServicesTwoMember | - | - | $6.26M | - | - |
| ClinicalServices1Member | - | - | $10.82M | - | - |
| ClinicalServicesThreeMember | - | - | $5.98M | - | - |
| Clinical Labs | - | - | - | $51.12M | - |
| Life Sciences | - | - | - | $30.05M | $29.94M |
| Consolidated | - | - | - | $81.17M | $104.71M |
Enzo Biochem's latest annual revenue breakdown by segment (product or service), as of Jul 22: Consolidated Member (100.00%).
Quarterly Revenue by Product
| Product/Service | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Apr 20 | Jan 20 | Oct 19 | Jul 19 | Apr 19 | Jan 19 | Oct 18 | Jul 18 | Apr 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consolidated Member | $20.28M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| ProductsMember | - | $7.59M | $10.37M | $6.78M | $7.78M | $7.48M | - | - | - | - | - | - | - | - | - | - | - |
| ClinicalServicesMember | - | $18.63M | $23.67M | $16.75M | $21.22M | $9.74M | - | - | - | - | - | - | - | - | - | - | - |
| ConsolidatedMember | - | $26.22M | $34.05M | $26.52M | $32.80M | $31.47M | - | - | - | - | - | - | - | - | - | - | - |
| ClinicalLabsMember | - | - | - | $19.74M | $25.02M | $23.99M | - | - | - | - | - | - | - | - | - | - | - |
| ClinicalServicesTwoMember | - | - | - | - | - | - | - | $2.56M | $1.66M | - | - | - | - | - | - | - | - |
| ClinicalServicesThreeMember | - | - | - | - | - | - | - | $1.87M | $1.13M | - | - | - | - | - | - | - | - |
| ClinicalServices1Member | - | - | - | - | - | - | - | $3.26M | $9.74M | - | - | - | - | - | - | - | - |
| Product Revenue | - | - | - | - | - | - | - | - | - | $6.87M | $7.43M | - | - | - | - | - | - |
| Life Sciences | - | - | - | - | - | - | - | - | - | - | - | $7.85M | $7.68M | $7.49M | - | - | - |
| Consolidated | - | - | - | - | - | - | - | - | - | - | - | $20.92M | $19.66M | $19.33M | $21.26M | $24.45M | $25.63M |
| Clinical Services | - | - | - | - | - | - | - | - | - | - | - | - | $11.75M | $12.00M | $14.30M | - | - |
| Products | - | - | - | - | - | - | - | - | - | - | - | - | $7.91M | $7.33M | $6.96M | - | - |
| Clinical Labs | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $16.78M | $18.14M |
Enzo Biochem's latest quarterly revenue breakdown by segment (product or service), as of Jul 22: Consolidated Member (100.00%).
Enzo Biochem Revenue Breakdown by Country
Annual Revenue by Country
| Country | Jul 23 | Jul 22 | Jul 21 | Jul 20 | Jul 19 |
|---|---|---|---|---|---|
| UNITED STATES | $18.55M | $19.78M | $102.60M | - | - |
| Asia Pacific | $4.06M | $4.29M | $4.74M | - | - |
| Europe | $8.45M | $8.57M | $10.39M | - | - |
| Consolidated Member | - | $107.07M | - | - | - |
| European Union | - | - | - | $7.48M | - |
| RestofworldMember | - | - | - | $4.50M | - |
| SWITZERLAND | - | - | - | - | $2.61M |
| Other International Countries | - | - | - | - | $4.56M |
Enzo Biochem's latest annual revenue breakdown by geography, as of Jul 23: UNITED STATES (59.72%), Europe (27.20%), and Asia Pacific (13.08%).
Quarterly Revenue by Country
| Country | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Apr 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific | $870.00K | $1.10M | $1.03M | $1.11M | $754.00K | $1.09M | $1.10M | $1.22K | $908.00 | $1.11M | $1.32M | - | - | - | - |
| UNITED STATES | $4.79M | $5.17M | $4.63M | $5.27M | $5.04M | $4.14M | $4.09M | $6.75K | $3.86K | $3.46M | - | - | - | - | - |
| Europe | $2.36M | $2.29M | $2.14M | $2.58M | $1.69M | $2.28M | $1.90M | - | - | - | - | - | - | - | - |
| Consolidated Member | - | - | - | - | - | - | - | $20.28M | - | - | - | - | - | - | - |
| European Union | - | - | - | - | - | - | - | - | $2.40K | $2.01K | $2.59M | $2.73M | $2.63M | $2.38M | $1.79M |
| RestofworldMember | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.17M | $1.17M |
Enzo Biochem's latest quarterly revenue breakdown by geography, as of Apr 24: UNITED STATES (59.75%), Europe (29.41%), and Asia Pacific (10.85%).
Enzo Biochem Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SHC | Sotera Health Company | $1.05B | $276.59M |
| GTH | Genetron | $650.71M | $201.32M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| LMDX | LumiraDx | $254.48M | $21.00M |
| CSTL | Castle Biosciences | $219.79M | $87.00M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| FONR | FONAR | $98.65M | $25.72M |
| STIM | Neuronetics | $71.35M | $16.45M |
| XGN | Exagen | $52.55M | $15.06M |
| BDSX | Biodesix | $49.09M | $14.82M |
| ENZ | Enzo Biochem | $31.06M | $8.02M |
| PMD | Psychemedics | $22.10M | $5.36M |
| DRIO | DarioHealth | $20.35M | $6.25M |
| SERA | Sera Prognostics | $306.00K | - |
ENZ Revenue FAQ
What is Enzo Biochem’s yearly revenue?
Enzo Biochem's yearly revenue for 2023 was $31.06M, representing a decrease of -70.99% compared to 2022. The company's yearly revenue for 2022 was $107.07M, representing a decrease of -9.05% compared to 2021. ENZ's yearly revenue for 2021 was $117.73M, representing an increase of 54.87% compared to 2020.
What is Enzo Biochem’s quarterly revenue?
Enzo Biochem's quarterly revenue for Q3 2024 was $8.02M, a -6.21% decrease from the previous quarter (Q2 2024), and a -50.20% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $8.55M, a 9.57% increase from the previous quarter (Q1 2024), and a -47.65% decrease year-over-year (Q2 2023). ENZ's quarterly revenue for Q1 2024 was $7.81M, a -139.70% decrease from the previous quarter (Q4 2023), and a -57.29% decrease year-over-year (Q1 2023).
What is Enzo Biochem’s revenue growth rate?
Enzo Biochem's revenue growth rate for the last 3 years (2021-2023) was -73.62%, and for the last 5 years (2019-2023) was -61.73%.
What are Enzo Biochem’s revenue streams?
Enzo Biochem's revenue streams in l 22 are Consolidated Member
What is Enzo Biochem’s main source of revenue?
For the fiscal year ending Jul 22, the largest source of revenue of Enzo Biochem was Consolidated Member. This segment made a revenue of $107.07M, representing 100.00% of the company's total revenue.